|
Phytoestrogens
& Your Baby
Don't doubt
it - phytoestrogens are bad for your baby.
Why expose your baby?
Many parents that
fed soy formulas in the 1960's did so after receiving the advice
that they were 'better than breast milk'. Had they known
that these products contained phytoestrogens, compounds that
are now known to cause thyroid disorders, behavioural and developmental
disorders and cancer they would not have even contemplated the
use of what was, in hindsight, an experimental product. |
|
|
Most parents feeding
soy formulas still have absolutely no idea that they contain
these potent endocrine disrupting compounds, and by not disclosing
the presence of phytoestrogens in their products, soy formula
manufacturers are in violation of the WHO code of marketing
breast-milk substitutes. For a review on the health concerns
raised about soy infant formula, read the Food
Commission Briefing Paper written by Dr Mike Fitzpatrick
and Sue Dibb. |
The message from Soy Online Service
is simple. Breast is best, everything else is greatly inferior.
If your child is lactose intolerant or allergic to dairy protein,
there are alternatives to soy. Soy Online Service advice is
do not feed a soy formula under any circumstances. Why?
Despite knowing for years about the toxic effects of phytoestrogens,
soy formula manufacturers have not acted to remove them from their
products. Infants fed soy formulas are still being exposed
to unacceptably high levels of phytoestrogens.
Why
are we so sure that phytoestrogens are bad for your baby?
And why, when the evidence is
plain are regulators not doing more to reduce the risk of exposing
developing infants to these potent endocrine disruptors?
The American Academy of Pediatrics
(AAP) has recently stated that a number of studies are currently
addressing the soy-formula/phytoestrogen issue. But this gives precious
little direction or peace of mind to those that are currently feeding,
or have been fed, a soy formula. So when and how is the phytoestrogen
issue likely to be resolved? In reality it could be years before
science provides the answers, and perhaps those answers will never
come. But if bodies such as the AAP don't know what to make of phytoestrogens,
and a real risk is recognised, then the only decision that can be
made is a precautionary one.
This is the essence of the ‘precautionary
principle', that is, a bona fide risk of harm that lacks some
degree of scientific certainty should not prevent regulators from
acting to protect those who are at risk of that harm.
In this instance the precautionary
principle would dictate that:
- until phytoestrogens are proven to be safe
for infants they should be removed from soy formulas.
- soy formula manufacturers should bear the burden
of proving the safety of phytoestrogens.
The fact is that there is strong
evidence of real harm being caused to soy formula fed infants by
phytoestrogens leaves little room for debate on whether the precautionary
principle should apply in this case.
The only ones likely to strongly
disagree with the precautionary approach are soy formula manufacturers.
In February 1998 the Infant Formula Council issued a statement on
phytoestrogens. Like previous statements from infant formula manufacturers,
their release was notable for its dismissal of any possible concern
and its total failure to address the real issues.
The Infant Formula Council argument
began by announcing that studies on infants fed soy formulas ‘have
not indicated any evidence of harmful effect'. This statement
is nonsense because there have been no studies that have specifically
investigated the potential harmful effects that phytoestrogens might
have on infants.
This statement is also incorrect.
Although there have been no direct investigations of the potential
harmful effects of phytoestrogens on infants, other studies provide
strong evidence that phytoestrogens in soy formulas do harm infants.
Firstly, the consumption of soy-based
formulas was associated with an increased occurrence of premature
thelarche in Puerto Rico. In 1982 Pediatric endocrinologists in
Puerto Rico reported on an increase in the incidence of breast development
in girls younger than eight years of age. Of the 552 diagnosed cases
reported between 1978 and 1982, a representative group of 130 were
studied in an attempt to identify possible factors that might have
contributed to what was considered an epidemic of premature thelarche.
Approximately 68 percent of the cases
(85 out of 130) studied experienced the onset of thelarche before
they were 18 months old. In these most overt cases, the investigators
found a positive statistical association between premature thelarche
and the consumption of soy formulas (22 cases), various meat products
(10 cases) and a maternal history of ovarian cysts (16 cases).
Despite the probability that phytoestrogens
in soy formulas were culpable in the Puerto Rico outbreak and the
fact that mounting evidence that the early onset of puberty is increasing
in the US (at the same time as soy formula sales reach record levels),
there have been no studies to further investigate the link between
soy formulas and premature thelarche.
What are the long term risks associated
with premature thelarche? There is still debate over whether or
not premature thelarche progresses to precocious puberty, but there
is evidence from several studies that shows that it does increase
the chance of early menarche. A higher incidence of ovarian cysts
has also been found in girls that develop breasts at an early age.
The earlier the onset of menarche, the greater the lifetime risk
of breast cancer, and the early incidence of ovarian cysts is an
established risk factor in the later development of ovarian cancer.
One can only wonder why the Infant Formula Council don't consider
the Puerto Rico cases of premature thelarche as evidence of harm.
Secondly, like many endocrine disruptors,
the soy phytoestrogens can cause thyroid dysfunction in humans.
Reports from the late 1950s and early 1960s found that infants fed
soy-flour formulas developed goitre, although the goitrogenic factors
were not isolated at that time. More recent reports have further
identified the actual toxicity of soy to the thyroid and mechanistic
investigations have determined that the anti-thyroid factors in
soy are the phytoestrogens.
Little doubt can remain that the
goitre in infants fed soy formulas was caused by the phytoestrogens.
Claims that phytoestrogens have had no effect on the infant endocrine
system just don't wash, unless of course the thyroid is no
longer part of the endocrine system. If further evidence is needed
that there is genuine cause for concern then it should be noted
that malignant goitre has also occurred in experimental animals
fed soy even when iodine is present in their diets and there is
clear potential for soy isoflavones to cause a range of thyroid
disorders in iodine sufficient humans.
It is possible, but unlikely, that
the Infant Formula Council are not aware that phytoestrogens cause
goitre. The soy industry has known that soy contains goitrogenic
agents for over 60 years and for more than 40 years it has been
known that these agents are also present in soy formulas. The cases
of goitre that were reported in soy formula fed infants in the late
1950's ceased when manufacturers added more iodine to their products.
But is the simple addition of more iodine to soy formulas an appropriate
way in which to counteract the goitrogenic and anti-thyroid effects
of the phytoestrogens?
To answer that question one must
understand how the soy phytoestrogens (isoflavones) act on the thyroid.
Isoflavonoid, and the related flavonoid, compounds are well known
goitrogens and anti-thyroid agents. They typically act against the
thyroid by inhibition of thyroid peroxidase (TPO). The soy isoflavones
are no exception. They are potent inhibitors of TPO, in fact they
are more potent than either of the anti-thyroid drugs PTU or MMI.
What is food for thought is that in vitro the isoflavones
inhibit TPO catalysed reactions at concentrations that are comparable
to those found in the plasma of human infants fed soy formulas.
The fact is that soy formula fed
infants appear to be at real risk of long term thyroid damage. If
you want to be sure your child will not be at risk of such harm
then the message is simple; avoid soy formulas. And just in case
you're told that there is no evidence that thyroid soy formulas
increase the risk of thyroid disease, consider the fact that a preliminary
report has found a significant association between feeding soy formulas
and the development of autoimmune thyroid disease (ATD). Although
the mechanism by which ATD may occur in infants fed soy formulas
was not discussed by the authors, ATD is associated with exposure
to estrogens.
So far the only government agency
to publicly acknowledge the potential of soy formulas to damage
your baby's thyroid is the New
Zealand Ministry of Health. Why not write to your health
agencies and ask them to warn parents of the dangers of soy formulas?
Why you shouldn't believe
soy formulas manufacturers?
They're just plain dishonest.
Take, for example IDFA (Infant and Dietetic Foods Association) in
the UK. In their 1 September 1999 letter to Jilly Rosser,
Editor of Practising Midwife, IDFA's Executive Secretary, Sarah
Jacobs, wrote:
"The accusation that soya-based
infant formulas have been part of a 'large, uncontrolled and basically
unmonitored infant experiment' is untrue. Soya infant formulas
have a long history of use and there is considerable body of evidence
based on human research studies and clinical trials to show that
they are safe and that infants thrive well on them".
In truth there is no evidence that
soy formulas are safe, but Dr Dan Sheehan's statement that infant
formula feed has been a 'large, uncontrolled and basically unmonitored
infant experiment' is accurate.
IDFA have been guilty of telling
porkies about soy formulas previously. In their 10 January
1995 Press Release 'Phytoestrogens and Soya Infant Formulas' IDFA
reported that:
- 1. levels of phytoestrogens
if soya infant formulas are low.
- 2. most of the effects
of phytoestrogens have been positive.
- 3. human milk contains
phytoestrogens.
The first two points are outright
lies. The latter point contains an element of truth.
The breast milk of women eating soy products does contain phytoestrogens
but the levels are more than 1000 times lower than the levels in
soy formulas. IDFA's attempt to dupe consumers into thinking
that infants exposed to soy formulas are only receiving low levels
of phytoestrogens, comparable with those found in breast milk is
viewed by Soy Online Service in the same light as the "better
than breast milk" line that infant formula manufacturers sold
consumers in the 1960's. And all this in the name of infant
nutrition! When will the deliberate deception end?
If you are concerned that soy formulas
may be responsible for a thyroid problem or some other developmental
disorder in your baby contact our medical expert; you may also receive
free legal advice from Soy Online Service. Contact:
webmaster@soyonlineservice.co.nz
- Bisphenol A in infant
formula at 'dangerous' levels, says group, 12/6/2007 by
Ahmed ElAmin. Bisphenol A (BPA), known
as the 'gender bender' chemical, leaches into liquid baby formula
from the linings of cans at levels dangerous to infant health,
according to new research published yesterday by a US environmental
group. The Environmental Working Group (EWG) said the research
reveals that Bisphenol-A, used to line nearly all infant formula
cans, was found in at levels "far higher" in the product
than those that leach from plastic bottles under normal use. EWG
had previously estimated that one out of every 16 infants fed
ready-to-eat liquid formula are exposed to BPA at doses exceeding
those that caused increased aggression and significant changes
in testosterone levels in laboratory animals.
Read more here
Soya Formula for Infants
Should Only Be Administered on Doctor's Advice, Says German Consumer
Safety Watchdog, 19-11-07: Infant formula and follow-up
formula based on cow's milk protein or soy protein is for
sale in the European Union. Soy formula should only be administered
to infants over a longer period when this is necessary on medical
grounds. If a mother is unable to breastfeed her baby,
she can fall back on infant formula from the drug store or supermarket.
Products made from soybean protein and from cow's milk are
on sale. Soybeans contain high concentrations of isoflavones. They
should, therefore, only be given to infants over longer periods
in exceptional, justified cases. Isoflavones are similar to the
female hormone oestrogen; however, they have a far weaker effect.
Furthermore, soybeans may also contain higher amounts of the plant
component, phytate. Professor Dr. Dr. Andreas Hensel, President
of the Federal Institute for Risk Assessment (BfR), comments, "Infant
formula and follow-up formula made from soy protein should only
be administered on medical grounds and then only under medical supervision."
Read more here
POSSIBLE
EFFECTS OF PHYTOESTROGENS IN SOY INFANT FORMULA Soy formula,
which contains phytoestrogens, genistein and daidzein (also called
isoflavones) is given to approximately 25% of those US children
fed formula. It is estimated that an infant exclusively fed soy
formula receives the estrogenic equivalent of at least five birth
control pills per day. By contrast, almost no phytoestrogens have
been detected in dairy-based infant formula or in human milk, even
when the mother consumes soy products. A recent study found that
babies fed soy-based formula had 13,000 to 22,000 times more isoflavones
in their blood than babies fed milk-based formula. Scientists have
known for years that isoflavones in soy products can depress thyroid
function, causing autoimmune thyroid disease and even cancer of
the thyroid. But what are the effects of soy products on the hormonal
development of the infant, both male and female? Read
the full article here.
Endocrine
disrupters and female reproductive health. McLachlan
JA, Simpson E, Martin M.
Department of Pharmacology, Tulane
University School of Medicine, and Environmental Endocrinology Laboratory,
Center for Bioenvironmental Research, Tulane and Xavier Universities,
New Orleans, LA 70118, USA. john.mclachlan@tulane.edu There
is growing evidence of the impact of estrogenic contaminants in
the environment. Studies have shown that male fish in detergent-contaminated
water express female characteristics, turtles are sex-reversed by
polychlorinated biphenyls (PCBs), male frogs exposed to a common
herbicide form multiple ovaries, pseudohermaphroditic offspring
are produced by polar bears, and seals in contaminated water have
an excess of uterine fibroids. Read
more here
News from
Soyatech.com - A substance found in soy-based
infant formula and over-the-counter dietary supplements affects
the development of ovaries and eggs in female infant mice,
according to a study conducted by researchers at the National Institutes
of Health (NIH) and Syracuse University. Read
the article here.
GM:
New study shows unborn babies could be harmed - Mortality
rate for new-born rats six times higher when mother was fed on a
diet of modified soya. Women who eat GM foods while pregnant
risk endangering their unborn babies, startling new research suggests.
The study - carried out by a leading scientist at the Russian Academy
of Sciences - found that more than half of the offspring of rats
fed on modified soya died in the first three weeks of life, six
times as many as those born to mothers with normal diets. Six times
as many were also severely underweight.
Healthy
Alternatives to Conventional Infant Formula - go here for cow
mik, goat-milk, liver, fortified commercial formula, egg yolk and
whey-based formula alternatives suggested by Dr Mercola.
Manganese
Content of Soy or Rice Beverages is High in Comparison to Infant
Formulas - read about the effects of Manganese in our Soy Toxins
section.
Soy
Products and Infant Leukemia
Artificial baby milks: how safe is soya?
"Two separate studies
-- one in animals and the other in humans -- that considered together
suggest that a diet high in soybeans and other legumes during pregnancy
and breastfeeding may have a subtle but long-term impact on the
development of children." writes Dr Mercola. Read
the full article here
Read the British Dietetic Associations
position on the use of soya protein for infants Here.
New
guidelines on infant feeding in the first 12 months of life by Judy
More, Royal London Hospital, London. Read
More Here
The United Kingdom Chief Medical
Officer has warned all doctors that soy-based infant formulas should
be used only in exceptional circumstances, because of a risk
to long term Reproductive Health.
Full information on the UK Expert Committee's findings are Here
In their Paediatric Policy, the Royal
Australasian College of Physicians Health Policy Unit outlines their
policy on the Use
of Soy Protein Formula.
The Insider's Guide to Natural Medicine"
is also alarmed at the harm soy does to baby's thyroid. Read
their opinion Here.
An article published in Scientific
American (2002) suggests soy infant formula may impair the developing
immune system.
Read More Here
Natural
Life Magazine #68 - Soy Infant Formula Dangerous to Babies, Say
Groups
Soy and children's health: a formula
for trouble. Follow this Link
to an article published in Environmental Health Perspectives.
The literature is replete with numerous
studies showing deleterious effects on multiple organ systems -
including the immune system. For example this letter from
the American
Journal of Clinical Nutrition.
"For the males, decreased
sperm count and enlarged prostates. The treatment altered virtually
every aspect of the reproductive system. The place next to the testes,
the duct system called the epididymis where the sperm are stored
prior to being ejaculated -- it was abnormally small, which could
account also for lowered sperm count in the ejaculate. But we know
also the testis is making fewer sperm. We see changes in growth
rate as well. One of the interesting things is that these very low
doses of estrogen increase rates of growth. The animals were actually
growing larger than they would have normally. It was really quite
a dramatic effect. The females went into puberty early. And we saw
changes in behavior, changes in reactivity to the presence of other
animals in the environment. Essentially the animals looked to be
somewhat hyper-reactive to stimuli. We have, in other words, effects
on brain and behavior. We're also seeing changes in liver enzyme
activity which determines the way we respond to external chemicals,
how fast we clear drugs, how we metabolize drugs.
In other words, in every aspect
of physiology that we look for, we see effects. And they're permanent.
And the important thing about what I'm talking about is we are only
exposing babies to these chemicals for very, very short periods
of time in development and the consequences are for the rest of
the life of that individual. Once you change the development of
an organ there is no way to undo that effect. It's a life sentence
-- that's a lifetime consequence. Medical science can't undo the
development of organs." Fredrick Vom Saal, Professor
of Biological Sciences, University of Missouri in an interview on
estrogenic chemicals in the environment conducted in February 1998
by Doug Hamilton, producer of FRONTLINE's "Fooling With Nature."
Full interview can be found here
For
further information on soy protein intolerance, follow this link
to eMedicine.com
Canadian
Health Coalition say Health Canada are exposing babies to serious
risk and recommend that the routine use of soy-based infant formulas
must be stopped.
It is already known to medical researchers
that thyroid dysfunction in a mother increases the risk of her baby
having subnormal thyroid and brain functions. This report
of research at
John Hopkins University supports the potential link between
isoflavone consumption during pregnancy, thyroid harm and birth
defects
There are links between high
soy diets during pregnancy and nursing and eventual developmental
changes in children. Congenital abnormalities of the genital
tract are also increasing, and once again soy phytoestrogens may
be implicated, according to a study that found a higher incidence
of birth
defects in male offspring of vegetarian, soy-consuming mothers.
"Excess consumption
of soy or other phytoestrogens also might contribute to pseudopuberty."
Soy has been linked as a potential clinical factor in the early
onset of puberty termed "Precocious Puberty".
Read more from eMedicine.com.
Read more about the potential effects
of soy on Male
Reproductive Health published in Endocrinology journal.
Soyonlineservice receives questions
about whether soy formulas are causing scoliosis in children. As
far as we know there has been no direct research on an association
between soy formulas and childhood scoliosis, presumably because
the industry has never admitted that it leaves this chemical in
its products. Howerver, the levels of phytic acid in soy protein
can run as high as 3% of the volume, and soy protein is 19% of soy
formulas. Therefore it is feasible and entirely possible for
its depletion to the later onset of scoliosis to result. Read
more about Other Soy Toxins Here.
Doerge DR, Twaddle NC, Churchwell MI, Newbold
RR, Delclos KB.
Division of Biochemical Toxicology, National Center
for Toxicological Research, U.S. Food and Drug Administration, Jefferson,
AR 72079, USA.
Exposures of Sprague-Dawley rats to the soy isoflavone,
genistein, throughout the entire lifespan have produced a number
of effects on reproductive tissues, immune function, neuroendocrine
function and behavior. Our previous studies investigated pharmacokinetics
and disposition of genistein during adult and fetal periods and
this study describes the internal exposures of post-natal day 10
(PND10) rat pups due to lactational transfer of genistein. Conjugated
and aglycone forms of genistein were measured by using LC/MS/MS
in serum (PND10) and milk (PND7) from lactating dams consuming a
genistein-fortified soy-free diet, and in serum from their pups
at a time when milk was the only food source (PND10). This study
shows that limited lactational transfer of genistein to rat pups
occurs and that internal exposures to the active aglycone form of
genistein are generally lower than those measured previously in
the fetal period. These results suggest that developmental effects
attributable to genistein exposure in our chronic and multi-generation
studies are more likely to result from fetal exposures because of
the higher levels of the active estrogenic aglycone form of genistein
in utero, although the possibility of neonatal responses cannot
be excluded.
- Exposure of infants to phyto-oestrogens
from soy-based infant formula
Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE.
Lancet 1997 Jul 5 350:9070 23-7.
Abstract
BACKGROUND: The isoflavones genistein, daidzein, and
their glycosides, found in high concentrations in soybeans and
soy-protein foods, may have beneficial effects in the prevention
or treatment of many hormone-dependent diseases. Because these
bioactive phyto-oestrogens possess a wide range of hormonal
and non-hormonal activities, it has been suggested that adverse
effects may occur in infants fed soy-based formulas.
- METHODS: To evaluate the extent of infant
exposure to phyto-oestrogens from soy formula, the isoflavone
composition of 25 randomly selected samples from five major
brands of commercially available soy-based infant formulas were
analysed, and the plasma concentrations of genistein and daidzein,
and the intestinally derived metabolite, equol, were compared
in 4-month-old infants fed exclusively soy-based infant formula
(n = 7), cow-milk formula (n = 7), or human breast-milk (n =
7). FINDINGS: All of the soy formulas contained mainly glycosides
of genistein and daidzein, and the total isoflavone content
was similar among the five formulas analysed and was related
to the proportion of soy isolate used in their manufacture.
From the concentrations of isoflavones in these formulas (means
32-47 micrograms/mL), the typical daily volume of milk consumed,
and average bodyweight, a 4-month-old infant fed soy formula
would be exposed to 28-47 per day, or about 4.5-8.0 mg/kg bodyweight
per day, of total isoflavones. Mean (SD) plasma concentrations
of genistein and daidzein in the seven infants fed soy-based
formulas were 684 (443) ng/mL and 295 (60) ng/mL, respectively,
which was significantly greater (p < 0.05) than in the infants
fed either cow-milk formulas (3.2 [0.7] and 2.1 [0.3] ng/mL),
or human breast-milk (2.8 [0.7] and 1.4 [0.1] ng/mL), and an
order of magnitude higher per bodyweight than typical plasma
concentrations of adults consuming soy foods.
- INTERPRETATION: The daily exposure of infants
to isoflavones in soy infant-formulas is 6-11 fold higher on
a bodyweight basis than the dose that has hormonal effects in
adults consuming soy foods. Circulating concentrations of isoflavones
in the seven infants fed soy-based formula were 13000-22000
times higher than plasma oestradiol concentrations in early
life, and may be sufficient to exert biological effects, whereas
the contribution of isoflavones from breast-milk and cow-milk
is negligible.
-
Isoflavone content of infant formulas and the metabolic
fate of these phytoestrogens in early life.
Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. Am
J Clin Nutr 1998 Dec 68:6 Suppl 1453S-1461S.
Abstract
Soy-based infant formulas have been in use for >30
y. These formulas are manufactured from soy protein isolates
and contain significant amounts of phytoestrogens of the isoflavone
class. As determined by HPLC, the isoflavone compositions of
commercially available formulas are similar qualitatively and
quantitatively and are consistent with the isoflavone composition
of soy protein isolates. Genistein, found predominantly in the
form of glycosidic conjugates, accounts for >65% of the isoflavones
in soy-based formulas. Total isoflavone concentrations of soy-based
formulas prepared for infant feeding range from 32 to 47 mg/L,
whereas isoflavone concentrations in human breast milk are only
5.6 +/- 4.4 microg/L (mean +/- SD, n = 9). Infants fed soy-based
formulas are therefore exposed to 22-45 mg isoflavones/d (6-11
mg x kg body wt(-1) x d(-1)), whereas the intake of these phytoestrogens
from human milk is negligible (<0.01 mg/d). The metabolic
fate of isoflavones from soy-based infant formula is described.
Plasma isoflavone concentrations reported previously for 4-mo-old
infants fed soy-based formula were 654-1775 microg/L (mean:
979.7 microg/L: Lancet 1997:350;23-7), significantly higher
than plasma concentrations of infants fed either cow-milk formula
(mean +/- SD: 9.4 +/- 1.2 microg/L) or human breast milk (4.7
+/- 1.3 microg/L). The high steady state plasma concentration
of isoflavones in infants fed soy-based formula is explained
by reduced intestinal biotransformation, as evidenced by low
or undetectable concentrations of equol and other metabolites,
and is maintained by constant daily exposure from frequent feeding.
Isoflavones circulate at concentrations that are 13,000-22,000-fold
higher than plasma estradiol concentrations in early life. Exposure
to these phytoestrogens early in life may have long-term health
benefits for hormone-dependent diseases.
Author Address
Clinical Mass Spectrometry Center, Children's Hospital
Medical Center, Cincinnati, OH 45229, USA.
- Phytoestrogens
in soy-based infant foods: concentrations, daily intake, and
possible biological effects.
Irvine CH, Fitzpatrick MG, Alexander SL. Proc
Soc Exp Biol Med 1998 Mar 217:3 247-53.
Abstract
Exposure to estrogenic compounds may pose a developmental
hazard to infants. Soy products, which contain the phytoestrogens,
genistein and daidzein, are becoming increasingly popular as
infant foods. To begin to evaluate the potential of the phytoestrogens
in these products to affect infants, we measured total genistein
and daidzein contents of commercially available soy-based infant
formulas, infant cereals, dinners, and rusks. We also assayed
phytoestrogens in dairy-based formulas and in breast milk from
omnivorous or vegetarian mothers. In most cases, the glucoside
forms of the phytoestrogens were hydrolyzed before separation
by HPLC. Mean (+/-SEM) total genistein and daidzein contents
in four soy infant formulas were 87+/-3 and 49+/-2 microg/g,
respectively. The phytoestrogen content of cereals varied with
brand, with genistein ranging from 3-287 microg/g and daidzein
from 2-276 microg/g. By contrast, no phytoestrogens were detected
in dairy-based infant formulas or in human breast milk, irrespective
of the mother's diet (detection limit = 0.05 microg/ml). When
fed according to the manufacturer's instruction, soy formulas
provide the infant with a daily dose rate of total isoflavones
(i.e., genistein + daidzein) of approximately 3 mg/kg body weight,
which is maintained at a fairly constant level between 0-4 months
of age. Supplementing the diet of 4-month-old infants with a
single daily serving of cereal can increase their isoflavone
intake by over 25%, depending on the brand chosen. This rate
of isoflavone intake is much greater than that shown in adult
humans to alter reproductive hormones. Since the available evidence
suggests that infants can digest and absorb dietary phytoestrogens
in active forms and since neonates are generally more susceptible
than adults to perturbations of the sex steroid milieu, we suggest
that it would be highly desirable to study the effects of soy
isoflavones on steroid-dependent developmental processes in
human babies.
- Author Address
Animal and Veterinary Sciences Group, Lincoln University,
Canterbury, New Zealand.
- Download
full paper.
The potential adverse effects
of soybean phytoestrogens in infant feeding [letter].
Irvine C, Fitzpatrick M, Robertson I, Woodhams D.
N Z Med J 1995 May 24 108:1000 208-9.
Download letter.
- Herbal medicines, phytoestrogens
and toxicity: risk:benefit considerations.
Sheehan DM. Proc Soc Exp Biol Med 1998 Mar 217:3
379-85.
Abstract
There are several suggested health benefits of phytoestrogens,
particularly those found in soy products. Herbal medicines are
also widely thought to confer health benefits. Additionally,
drugs are prescribed to improve human health, but unlike phytoestrogens
and herbal medicines, toxicities are defined in experimental
animals and monitored in humans before and after marketing.
Knowledge of toxicity is crucial to decrease the risk:benefit
ratio; this knowledge defines appropriate conditions for use
and strategies for development of safer products. However, our
awareness of the toxicity of herbal medicines and phytoestrogen-containing
foods is dramatically limited compared to drugs. Some aspects
of the toxicity of herbal medicines are briefly reviewed; it
is concluded that virtually all of our knowledge is derived
from human exposures leading to acute toxicities. Importantly,
detection of toxicity is sporadic, and little information is
available from prior animal experimentation. Additionally, well-organized
monitoring of human populations (as occurs for drugs) is virtually
nonexistent. Important toxicities with long latencies are particularly
difficult to associate with a causative agent during or even
after large scale exposures, as exemplified by tobacco smoking
and lung cancer; estrogen replacement therapy and endometrial
cancer; diethylstilbestrol and reproductive tract cancers; and
fetal alcohol exposure and birth defects. These considerations
suggest that much closer study in experimental animals and human
populations exposed to phytoestrogen-containing products, and
particularly soy-based foods, is necessary. Among human exposures,
infant soy formula exposure appears to provide the highest of
all phytoestrogen doses, and this occurs during development,
often the most sensitive life-stage for induction of toxicity.
Large, carefully controlled studies in this exposed infant population
are a high priority.
Author Address
Department of Health and Human Services, Food and Drug
Administration, Jefferson, Arkansas 72079-9502.
Isoflavone content of breast
milk and soy formulas: benefits and risks [letter]
Sheehan DM. Clin Chem 1997 May 43:5 850.
- The case for expanded phytoestrogen
research.
Sheehan DM. Proc Soc Exp Biol Med 1995 Jan 208:1 3-5.
Effects of lactational exposure to soy isoflavones on reproductive system in neonatal female rats.
Liu Z, Zhang X, Li L, Zhang W, Cui W, Song Y, Wang W, Jia X, Li N, Yan W, Basic Clin Pharmacol Toxicol. 2008 Mar;102(3):317-24.
Lactational exposure to
isoflavones could result in oestrogen-like actions on the reproductive
system of neonate female rats, which mechanisms may be, at least,
involved with modifications of hormone production and steroid receptor
transcription in the reproductive system.
Full
Abstract Here
Genistein at a concentration
present in soy infant formula inhibits Caco-2BBe cell proliferation
by causing G2/M cell cycle arrest.
Chen AC, Donovan SM. J Nutr. 2004 Jun;134(6):1303-8.
Thus, a biphasic effect of genistein
was seen with a low dose stimulating intestinal cell proliferation
through the estrogen receptor, whereas a high dose of genistein
inhibited intestinal cell proliferation and altered cell cycle dynamics.
A high dose of genistein may potentially compromise intestinal growth.
Full
Abstract Here
Manipulation of prenatal
hormones and dietary phytoestrogens during adulthood alter the sexually
dimorphic expression of visual spatial memory.
Lund TD, Lephart ED. BMC Neurosci. 2001;2(1):21. Epub 2001
Dec 18.
Full
Abstract Here
Hypocalcemic tetany in 'alternative'
soy milk nutrition in the first months of life
Anil M, Demirakca S, Dotsch J, Kiess W. Klin Padiatr. 1996
Nov-Dec;208(6):323-6.
A 14 weeks old infant was admitted
to the intensive care unit with life-threatening hypocalcemic-hyperphosphatemic
spasms. Hypocalcemia-hyperphosphatemia was found to have been caused
by feeding a high phosphate/ low calcium soy milk. The daily uptake
of calcium was calculated to have been 3.3-6 mmol that of phosphate
30 mmol. The parents strongly believed that soy milk formulas were
equivalent to breast milk and cow's milk formulas and lived on a
strictly vegetarian diet.
Vegetarian feeding had led
to life-threatening hypocalcemic hyperphosphatemic spasms in the
infant. We conclude that malnutrition and false nutritional beliefs
have to be included as a potential cause of early hypocalcemia in
infants.
Full Abstract Here
Read more on milk alternative
issues on our Chicken Roost page
The phenotype of the aromatase
knockout mouse reveals dietary phytoestrogens impact significantly
on testis function.
Robertson KM, O'Donnell L, Simpson ER, Jones ME. Endocrinology
2002 Aug;143(8):2913-21
Our study highlights the importance
of estrogen in spermatogenesis and shows that relatively low levels
of dietary phytoestrogens have a biological effect in the testis.
Full
Abstract Here
Estrogen and spermatogenesis.
O'Donnell L, Robertson KM, Jones ME, Simpson ER. Endocr
Rev 2001 Jun;22(3):289-318
This review highlights the ability
of exogenous estrogen exposure to perturb spermatogenesis and male
fertility, as well as the emerging physiological role of estrogens
in male fertility, suggesting that, in this local context, estrogenic
substances should also be considered "male hormones."
Full Abstract Here
Premature thelarche in Puerto
Rico. A search for environmental factors.
Freni-Titulaer LW, Cordero JF, Haddock L, Lebrón G, Martínez
R, Mills JL. Am J Dis Child 1986 Dec 140:12 1263-7.
Abstract
Pediatric endocrinologists in Puerto Rico reported a threefold
increase in the number of patients with
premature thelarche seen between 1978 and 1981. A matched-pairs
case-control study was conducted to evaluate associations with potential
environmental exposures to substances with estrogenic activity,
as well as with familial factors. Analysis was performed on 120
pairs, the case subjects of which were selected from those diagnosed
between 1978 and 1982. In subjects 2 years of age or older at the
onset of thelarche, no significant associations were found. In subjects
with onset before 2 years of age, significant positive associations
were found with a maternal history of ovarian cysts, consumption
of soy-based formula, and consumption of various meat products.
A statistically significant negative association was found with
consumption of corn products. These statistical associations are
probably not sufficient to explain the reported increase because
in over 50% of the case subjects there was no exposure to any of
the risk factors for which statistical associations were found.
Exposure to other substances with possible estrogenic effect, such
as waste products from pharmaceutical factories and pesticides,
was also excluded as a possible cause. These findings suggest that
better diagnosis and reporting, or conceivably the presence of entirely
new, unsuspected factors, could account for the reported increase.
Developmental effects of
dietary phytoestrogens in Sprague-Dawley rats and interactions of
genistein and daidzein with rat estrogen receptors alpha and beta
in vitro.
Casanova M, You L, Gaido KW, Archibeque-Engle S, Janszen
DB, Heck HA. Toxicol Sci 1999 Oct;51(2):236-44
...effects of dietary genistein included
a decreased rate of body-weight gain, a markedly increased (2.3-fold)
uterine/body weight (U/BW) ratio on postnatal day (pnd) 21, a significant
acceleration of puberty among females...
Full
Abstract Here
Soy isoflavone supplements
antagonize reproductive behavior and estrogen receptor alpha- and
beta-dependent gene expression in the brain.
Patisaul HB, Dindo M, Whitten PL, Young LJ. Endocrinology
2001 Jul;142(7):2946-52
Supplement treatment also resulted
in a significant decrease in receptive behavior in estrogen- and
progesterone-primed females. The observed disruption of sexual receptivity
by the isoflavone supplement is probably due to antiestrogenic effects
observed in the brain.
Full
Abstract Here
Effect of estradiol and soy
phytoestrogens on choline acetyltransferase and nerve growth factor
mRNAs in the frontal cortex and hippocampus of female rats.
Pan Y, Anthony M, Clarkson TB. Proc Soc Exp Biol Med
1999 Jun;221(2):118-25
Our data suggest that soy phytoestrogens
may function as estrogen agonists in regulating ChAT and NGF mRNAs
in the brain of female rats.
Full
Abstract Here
Influence of perinatal genistein
exposure on the development of MNU-induced mammary carcinoma in
female Sprague-Dawley rats.
Yang J, Nakagawa H, Tsuta K, Tsubura A. Cancer Lett 2000
Feb 28;149(1-2):171-9
Genistein treatment during the perinatal
period resulted in lower body weight and lower relative uterine-ovarian
weight at 35 days, and a prolonged estrus cycle with a long estrus
phase at 12-16 weeks.
Thus, perinatal genistein is an endocrine
disrupter and increases the multiplicity of MNU-induced mammary
carcinoma in rats.
Full
Abstract Here
Neurobehavioral actions of
coumestrol and related isoflavonoids in rodents.
Whitten PL, Patisaul HB, Young LJ. Neurotoxicol Teratol
2002 Jan-Feb;24(1):47-54
Treatment of rat dams with a 100-ppm
coumestrol diet from birth to postnatal day (PND) 21 induced premature
anovulation in female offspring, and treatment from birth to PND
10 suppressed sexual behavior in male offspring.
Full
Abstract Here
Cross-species and interassay
comparisons of phytoestrogen action.
Whitten PL, Patisaul HB. Environ Health Perspect 2001 Mar;109
Suppl 1:5-20
In vivo data show that phytoestrogens
have a wide range of biologic effects at doses and plasma concentrations
seen with normal human diets. Significant in vivoresponses have
been observed in animal and human tests for bone, breast, ovary,
pituitary, vasculature, prostate, and serum lipids. The doses reported
to be biologically active in humans (0.4--10 mg/kg body weight/day)
are lower than the doses generally reported to be active in rodents
(10--100 mg/kg body weight/day), although some studies have reported
rodent responses at lower doses.
Full
Abstract Here
Placental transfer of the
soy isoflavone genistein following dietary and gavage administration
to Sprague Dawley rats.
Doerge DR, Churchwell MI, Chang HC, Newbold RR, Delclos
KB. Reprod Toxicol 2001 Mar-Apr;15(2):105-10
These studies show that genistein
aglycone crosses the rat placenta and can reach fetal brain from
maternal serum genistein levels that are relevant to those observed
in humans.
Full
Abstract Here
Mass spectrometric determination
of Genistein tissue distribution in diet-exposed Sprague-Dawley
rats.
Chang HC, Churchwell MI, Delclos KB, Newbold RR, Doerge DR.
J Nutr 2000 Aug;130(8):1963-70
Endocrine-responsive tissues including brain, liver, mammary,
ovary, prostate, testis, thyroid and uterus showed significant dose-dependent
increases in total genistein concentration.
Full
Abstract Here
Genistein exerts estrogen-like
effects in male mouse reproductive tract.
Strauss L, Makela S, Joshi S, Huhtaniemi I, Santti R. Mol
Cell Endocrinol 1998 Sep 25;144(1-2):83-93
...genistein (2.5 mg s.c./kg of body
weight/day for 9 days) reduced testicular and serum testosterone
concentrations, pituitary LH-content and prostate weight.
These results suggest that in adult
males, genistein induces the typical estrogenic effects in doses
comparable to those present in soy-based diets.
Full
Abstract Here
Maternal exposure to genistein
during pregnancy increases carcinogen-induced mammary tumorigenesis
in female rat offspring.
Hilakivi-Clarke L, Cho E, Onojafe
I, Raygada M, Clarke R. Oncol Rep 1999 Sep-Oct;6(5):1089-95
A high estrogenic environment in
utero may increase subsequent breast cancer risk.
Our results suggest that a maternal
exposure to subcutaneous administration of genistein can increase
mammary tumorigenesis in the offspring, mimicking the effects of
in utero estrogenic exposures. Further, increased ER protein levels
and reduced PKC activity in the mammary gland may be involved in
increasing susceptibility to carcinogen-induced mammary tumorigenesis
in rats exposed to genistein in utero.
Full
Abstract Here
Effects of dietary genistein
exposure during development on male and female CD (Sprague-Dawley)
rats.
Delclos KB, Bucci TJ, Lomax LG, Latendresse JR, Warbritton
A, Weis CC, Newbold RR. Reprod Toxicol 2001 Nov;15(6):647-63
Human exposure to genistein is predominantly
through consumption of soy products, including soy-based infant
formula and dietary supplements.
Body weight and feed consumption
of the treated dams prior to parturition showed a decreasing trend
with a significant reduction at the highest dose. Litter birth weight
was depressed in the 1250 ppm dose group, and pups of both sexes
in that dose group had significantly decreased body weights relative
to controls at the time of sacrifice. The most pronounced organ
weight effects in the pups were decreased ventral prostate weight
in males at the 1250 ppm dose and a trend toward higher pituitary
gland to body weight ratios in both sexes. Histopathologic examination
of female pups revealed ductal/alveolar hyperplasia of the mammary
glands at 250 to 1250 ppm. Ductal/alveolar hyperplasia and hypertrophy
also occurred in males, with significant effects seen at 25 ppm
and above. Abnormal cellular maturation in the vagina was observed
at 625 and 1250 ppm, and abnormal ovarian antral follicles were
observed at 1250 ppm. In males, aberrant or delayed spermatogenesis
in the seminiferous tubules relative to controls was observed at
1250 ppm. There was a deficit of sperm in the epididymis at 625
and 1250 ppm relative to controls, although testicular spermatid
head counts and epididymal spermatozoa counts did not show significant
differences from controls at these doses. Both sexes showed an increase
in the incidence and/or severity of renal tubal mineralization at
doses of 250 ppm and above.
Dietary genistein thus produced effects
in multiple estrogen-sensitive tissues in males and females that
are generally consistent with its estrogenic activity. These effects
occurred within exposure ranges achievable in humans.
Full
Abstract Here
- The phytoestrogen genistein induces thymic
and immune changes: A human health concern?
- Srikanth Yellayi*, Afia Naaz*, Melissa A.
Szewczykowski*, Tomomi Sato*, Jeffrey A. Woods, Jongsoo Chang§,
Mariangela Segre¶, Clint D. Allred§, William G. Helferich§,,
and Paul S. Cooke* Proc. Natl. Acad. Sci. USA, Vol. 99, Issue
11, 7616-7621, May 28, 2002
Use of soy-based infant formulas
and soy/isoflavone supplements has aroused concern because of potential
estrogenic effects of the soy isoflavones genistein and daidzein.
...genistein produced suppression
of humoral immunity.
Genistein injected at 8 mg/kg per
day produced serum genistein levels comparable to those reported
in soy-fed human infants, and this dose caused significant thymic
and immune changes in mice.
Critically, dietary genistein at
concentrations that produced serum genistein levels substantially
less than those in soy-fed infants produced marked thymic atrophy.
These results raise the possibility that serum genistein concentrations
found in soy-fed infants may be capable of producing thymic and
immune abnormalities, as suggested by previous reports of immune
impairments in soy-fed human infants.
Full Abstract Here
|